CAR T-CELL THERAPY AND THE CRUCIAL ROLE OF THE PRIMARY ONCOLOGY TEAM
LESSONS LEARNED
Join your colleagues to learn about incorporating CAR T Cell Therapy into your practice as we:
• Review unmet needs in relapsed or refractory hematologic malignancies
• Identify challenges to timely patient identification and referral
• Provide clarity on the primary oncologist role in the CAR T-cell therapy process
Tuesday, January 10 | 5:30 PM CST
PRESENTED BY
Ran Reshef, MD Director, Translational Research,
Blood and Marrow Transplantationer
Columbia University Medical Center
LOC A TION
Ruth's Chris Steak House
17840 Dallas Pkwy
Dallas, TX 75287
Please RSVP or email by 1/9/2023 to Laura Andrews at landrews01@kitepharma.com or 214-9013888.Kite does not provide or reimburse for alcohol at Speaker Programs. If you are a licensed US healthcare professional, the meal (if any) associated with this program may be reportable under the federal Open Payments/Sunshine Act and/or state law. Kite policy and the PhRMA Code limit attendance at this promotional educational program to healthcare professionals. Attendance by guests cannot be accommodated.
1_10_23_CAR_T_Program.pdf